| Name | 5-fluoro MN-18 |
|---|
| Formal Name | 1-(5-fluoropentyl)-N-1-naphthalenyl-1H-indazole-3-carboxamide |
|---|
| SMILES | O=C(Nc2cccc1ccccc12)c4nn(CCCCCF)c3ccccc34 |
|---|
| InChI Key | XBSWUIWDRFCAGZ-UHFFFAOYAH |
|---|
| InChI Code | inChI=1/C23H22FN3O/c24-15-6-1-7-16-27-21-14-5-4-12-19(21)22(26-27)23(28)25-20-13-8-10-17-9-2-3-11-18(17)20/h2-5,8-14H,1,6-7,15-16H2,(H,25,28) |
|---|
| Description | 5-fluoro MN-18 is a synthetic cannabinoid modeled after the potent cannabinoid agonist AM2201 (Ki = 1.0nM for CB1, 2.6nM for CB2). in that the indole ring of AM2201 has been replaced with an indazole moiety, and the acyl naphthyl group at the 3 position of the indole has been replaced with a 1-aminonaphthylcarboxamide group. 5-fluoro MN-18 began appearing on illicit drug sites during the summer of 2013. Although the physiological and toxicological properties of this compound have not yet been reported, other indazole-based cannabinoid agonists with reported binding affinities such as AKB48 have been detected in herbal smoking mixtures. |
|---|
Status |
Verified |
|---|
| Submitted | 2015-10-01 |
|---|
| Submitted By | Cayman Chemical
Georgia Bureau of Investigation, Headquarters Laboratory – Decatur, GA |
|---|
| Published | 2015-11-16 |
|---|
| Contact | Paul D. Kennedy, PhD. at Cayman Chemical |
|---|
| Product Details | Link |
|---|
Monograph |
Download the 5-fluoro MN-18 Monograph |
|---|
|
|
